Mostrar el registro sencillo del ítem

dc.contributor.authorBurgos-Molina, Antonio Manuel 
dc.contributor.authorAlamilla Presuel, Juan Carlos
dc.contributor.authorGonzález Vidal, Alejandro
dc.contributor.authorRuiz-Gómez, Miguel José 
dc.date.accessioned2023-01-12T10:05:29Z
dc.date.available2023-01-12T10:05:29Z
dc.date.created2023
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/10630/25722
dc.description.abstractCells need energy to survive, therefore, they increase the different pathways available to obtain it. This suggests that the cell, due to the cytotoxicity of bleomycin, increases the routes to obtain energy. For this reason, GPM1 could be a good candidate as bleomycin chemo-resistance biomarker. Knowing of the homologous gene in humans facilitates more studies of the expression of this protein in tumors.es_ES
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.es_ES
dc.language.isoenges_ES
dc.publisherAseicaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMetabolismo - Congresoses_ES
dc.subject.otherMetabolismes_ES
dc.subject.otherDrug resistancees_ES
dc.titleMetabolism is altered in the process of drug resistance acquisitiones_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.centroFacultad de Medicinaes_ES
dc.relation.eventtitle18th ASEICA INTERNATIONAL CONGRESSes_ES
dc.relation.eventplaceSantiago de Compostela, España.es_ES
dc.relation.eventdate16 al 18 de Noviembre 2022es_ES
dc.rights.ccAttribution-NonCommercial-NoDerivatives 4.0 Internacional*


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional